All stocks today
68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Santen Pharmaceutical Co., Ltd. revenue reports

Santen Pharmaceutical Co., Ltd. financial reports, Santen Pharmaceutical Co., Ltd. annual revenue in 2019. When does Santen Pharmaceutical Co., Ltd. report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 60 816 000 000 $ - 8 578 000 000 $ -
31/12/2018 58 866 000 000 $ - 8 995 000 000 $ -
30/09/2018 57 861 000 000 $ - 7 526 000 000 $ -
30/06/2018 56 483 000 000 $ - 6 854 000 000 $ -
Show:
to

Santen Pharmaceutical Co., Ltd. financial report charts

Santen Pharmaceutical Co., Ltd. quarterly report dates

  31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
39 866 000 000 $ 34 824 000 000 $ 35 111 000 000 $ 33 461 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
20 950 000 000 $ 24 042 000 000 $ 22 750 000 000 $ 23 022 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
60 816 000 000 $ 58 866 000 000 $ 57 861 000 000 $ 56 483 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
11 442 000 000 $ 12 832 000 000 $ 10 809 000 000 $ 10 015 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
8 578 000 000 $ 8 995 000 000 $ 7 526 000 000 $ 6 854 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
6 668 000 000 $ 6 128 000 000 $ 5 345 000 000 $ 5 619 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
49 374 000 000 $ 46 034 000 000 $ 47 052 000 000 $ 46 468 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
194 742 000 000 $ 188 851 000 000 $ 186 941 000 000 $ 174 440 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
391 186 000 000 $ 388 284 000 000 $ 400 030 000 000 $ 378 420 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
70 796 000 000 $ 75 394 000 000 $ 75 237 000 000 $ 57 483 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
60 663 000 000 $ 48 679 000 000 $ 51 785 000 000 $ 48 650 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
98 614 000 000 $ 89 515 000 000 $ 95 433 000 000 $ 89 133 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
25.21 % 23.05 % 23.86 % 23.55 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
290 900 000 000 $ 297 122 000 000 $ 302 914 000 000 $ 287 580 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
10 200 000 000 $ 5 445 000 000 $ 20 456 000 000 $ -3 207 000 000 $

Last revenue report of Santen Pharmaceutical Co., Ltd. was 31/03/2019. According to last financial report total revenue in Santen Pharmaceutical Co., Ltd. was 60 816 000 000 US dollar and changed by 0% since last year. Net income in Santen Pharmaceutical Co., Ltd. was 8 578 000 000 $ in last quartal, net income changes to 0%.

Santen Pharmaceutical Co., Ltd. stocks data

Santen Pharmaceutical Co., Ltd. financials